BNY Mellon · REGN Holdings Trend
Regeneron Pharmaceuticals · SEC 13F
BNY Mellon Holdings of REGN by Quarter
Quarter Shares Value
| Quarter | Shares | Value | QoQ Change |
|---|---|---|---|
| 2024Q1 | 887K | $853M | — |
| 2024Q2 | 864K | $908M | +6.5% |
| 2024Q3 | 715K | $752M | -17.2% |
| 2024Q4 | 689K | $491M | -34.7% |
| 2025Q1 | 698K | $443M | -9.8% |
| 2025Q2 | 657K | $345M | -22.2% |
| 2025Q3 | 672K | $378M | +9.5% |
| 2025Q4 | 764K | $590M | +56.2% |
| 2026Q1 | 765K | $591M | +0.3% |
← Back to REGN holders ← Back to REGN profile
Data source: SEC EDGAR Form 13F